SCAI statement on drug-eluting stents: practice and health care delivery implications

Catheter Cardiovasc Interv. 2003 Mar;58(3):397-9. doi: 10.1002/ccd.10513.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Angiogenesis Inhibitors / therapeutic use
  • Blood Vessel Prosthesis Implantation / adverse effects
  • Blood Vessel Prosthesis Implantation / standards
  • Delivery of Health Care / standards*
  • Drug Administration Routes*
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / prevention & control*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / therapeutic use
  • Practice Guidelines as Topic / standards*
  • Practice Patterns, Physicians' / standards*
  • Stents / adverse effects
  • Stents / standards*

Substances

  • Angiogenesis Inhibitors
  • Immunosuppressive Agents